Distribution of extracellular signal-regulated kinase 1- and 2-activated neurons in the rat periaqueductal gray matter after noxious stimulation.
The periaqueductal gray matter (PAG), the midbrain region made up of neuronal columns encircling the cerebral aqueduct, plays a key role in nociception. As the extracellular signal-regulated kinases (ERKs) 1 and 2 are activated after noxious stimulation, we analyzed the distribution of ERK-activated neurons in the PAG after visceral noxious stimulation. Ether- and urethane-anesthetized rats received an intraperitoneal injection of acetic acid or were left untreated and were perfused after 2 hr. Serial sections immunoreacted with an antibody selective for the activated ERKs. Significant ERK activation occurred only in the ether-anesthetized noxious stimulated rats. In these rats, we evaluated the number of ERK-activated neurons and their density as the ratio of the number of immunolabeled neurons to the extension of the region where they were located. ERK-activated neurons were more numerous in the lateral (LPAG) and ventrolateral (VLPAG) columns, but without significant differences. No ERK activation was seen in neurons of the most rostral PAG. The ERK-activated neurons were significantly denser at the intermediate level of the PAG. At the caudal level, they were denser in the LPAG and VLPAG columns, and in the DPAG column at the intermediate and rostral level. These findings suggest that noxious stimulation activates ERKs in neurons involved in the different functional activities related to nociception, overlapping in the PAG columns, and strengthens the role of PAG in integration.
Gioia
Magda
M
Department of Human Morphology, Laboratori Interdisciplinari Tecnologie Avanzante (L.I.T.A.) Segrate, University of Milan, Milan, Italy. magda.gioia@unimi.it
Moscheni
Claudia
C
Gagliano
Nicoletta
N
D019342:Acetic Acid / Q000494:pharmacology; D018685:Anesthetics, Inhalation; D000818:Animals; D015415:Biomarkers / Q000378:metabolism; D004986:Ether; D007124:Immunoenzyme Techniques; D007274:Injections, Intraperitoneal; D019950:Mitogen-Activated Protein Kinase 1 / Q000378:metabolism*; D048052:Mitogen-Activated Protein Kinase 3 / Q000378:metabolism*; D009474:Neurons / Q000187:drug effects / Q000201:enzymology* / Q000473:pathology; D010487:Periaqueductal Gray / Q000187:drug effects / Q000201:enzymology* / Q000473:pathology; D051381:Rats; D017208:Rats, Wistar; D014520:Urethane
D018685:Anesthetics, Inhalation; D015415:Biomarkers; D004986:Ether; D014520:Urethane; D019950:Mitogen-Activated Protein Kinase 1; D048052:Mitogen-Activated Protein Kinase 3; D019342:Acetic Acid